Rx-360 Responding to the Threat of Illicit Medicines: Methodologies for Monitoring, Investigation & Stakeholder Engagement
Rx-360 Understanding the Threat of Illicit Medicines: An Overview of Counterfeit, Tampered, Unapproved and Diverted Pharmaceuticals
Rx-360 Supply Chain Security: Prevention of Re-use of Genuine Packaging Components for Counterfeit Products
FDA Alerts Drug Makers of a Recall of Porcine Thyroid API from Sichuan Friendly Pharmaceutical Co., Limited, China
Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets
Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration
Definitions of Suspect Product & Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act Guidance
FDA Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification
